|
|
|
| Effect of Budesonide combined with Salbutamol Aerosol Inhalation in the treatment of acute exacerbation of chronic obstructive pulmonary disease |
| LI Yan |
| Department of Internal Medicine,Hospital of Traditional Chinese Medicine of Sihui City in Guangdong Province,Sihui 526200,China |
|
|
|
|
Abstract Objective To investigate the clinical effect of Budesonide combined with Salbutamol Aerosol Inhalation in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Methods A total of 270 AECOPD patients collected in our hospital from January 2016 to March 2017 were selected and randomly divided into the Budesonide monotherapy group,the Salbutamol monotherapy group and the combination group,which were called group A,B and C.The three groups were all given basic treatment.On the basis of basic treatment,patients in group A were given Budesonide suspension,group B was given Salbutamol Sulfate,group C was given Budesonide suspension and Salbutamol Sulfate.The clinical efficacy,6 min walking distance (6 MWD),dyspnea score and lung function were observed in the three groups,as well as the occurrence of adverse reactions.Results The total effective rate of group C was 96.67%,which was significantly higher than that of group A and B (P＜0.01).There was no significant difference in the total efficiency of group A and B (P＞0.05).Meanwhile,after treatment,the 6MWD scores,dyspnea scores and pulmonary function indexes of the three groups of A,B and C improved significantly(P＜0.01),and the improvement rate of group C was significantly higher than that of group A and B (P＜0.05),but there was no significant difference between group A and B(P＞0.05).There was no significant difference in the incidence of adverse reactions between the three groups(P＞0.05).Conclusion In the treatment of AECOPD,Budesonide combined with Salbutamol Aerosol Inhalation is better than that single drug inhalation.It has better clinical effect,which can significantly improve the clinical symptoms and lung function,and the incidence of adverse reactions is low.It is worth promoting widely in clinic.
|
|
|
|
|
|
| [1] |
黄雪英.莫西沙星治疗慢性阻塞性肺疾病急性加重期临床观察[J].现代预防医学，2010，37（12）：2386-2387.
|
| [2] |
Sonstein L，Clark C，Seidensticker S，et al.Improving adherence for management of acute exacerbation of chronic obstructive pulmonary disease[J].Am J Med，2014，127（11）：1097.
|
| [3] |
林珠.沙丁胺醇雾化吸入治疗慢性阻塞性肺病急性加重期的临床疗效及护理[J].中国基层医药，2010，17（20）：2863-2864.
|
| [4] |
何桦，郑劲平.吸入型激素和吸入型长效β2受体激动剂在COPD中的联合应用[J].国外医学呼吸系统系统分册，2009，23（3）：185-186
|
| [5] |
Sund ZM，Powell T，Greenwood R，et al.Remote daily realtimemonitoring in patients with COPD-a feasibility study using a noveldevice[J].Respir Med，2009，103（9）：1320-1328.
|
| [6] |
欧宗兴.慢性阻塞性肺疾病加重期联合雾化吸入长效受体激动剂及糖皮质激素疗效观察[J].现代预防医学，2009，36（2）：392-394.
|
| [7] |
徐峰，吴宗强，邬东平.布地奈德联合沙丁胺醇吸入治疗50例慢性阻塞性肺疾病急性加重期的临床观察[J].右江医学，2012，38（3）：265-267.
|
| [8] |
钱朝霞，何艳，方陈，等.不同剂量布地奈德雾化吸入和泼尼松龙静脉用药治疗AECOPD的对比研究[J].临床肺科杂志，2010，15（4）：488-490.
|
| [9] |
Sun WP，Yuan GX，Hu YJ，et al.Effect of low-dose glu-cocorticoid on corticosteroid insufficient patients with acute exacerbation of chronic obstructive pulmonary disease[J].World J Emerg Med，2015，6（1）：34.
|
| [10] |
王沁，宋德胤.布地奈德联合沙丁胺醇雾化吸入治疗AECOPD的疗效及对肺功能相关指标的影响[J].实用临床医药杂志，2016，20（7）：38-40.
|
| [11] |
杨洪涛，陈哲，宋爱芹.雾化吸入布地奈德联合沙丁胺醇治疗慢性阻塞性肺疾病急性加重期的疗效及对肺功能相关指标的影响[J].实用临床医药杂志，2017，21（15）：118-119.
|
| [12] |
王志新，陈宏民，乔红伟.联合吸入噻托溴铵和布地奈德混悬液治疗COPD的疗效观察[J].临床肺科杂志，2010，15（5）：629-630.
|
| [13] |
龚辉.布地奈德联合沙丁胺醇治疗慢性阻塞性肺疾病急性加重期的效果观察[J].临床合理用药杂志，2016，9（26）：27-28.
|
| [14] |
沈立飞，张水定，戴新刚.普米克令舒吸入与静脉注射甲基泼尼松龙治疗COPD急性发作期疗效对比观察[J].中国卫生产业，2014，11（15）：91-92.
|
| [15] |
吴艳辉，陈新忠.沙丁胺醇预先给药对慢性阻塞性肺疾病患者腹腔镜手术呼吸力学的影响[J].中国现代医生，2013，51（34）：113-115，118.
|
| [16] |
彭绍华，洪英，林忠.沙丁胺醇、布地奈德雾化吸入联合盐酸氨溴索静滴治疗AECOPD的临床研究[J].中外医学研究，2017，15（21）：118-119.
|
| [17] |
Bayiz H，Ozkaya S，Dirican A，et al.The rapid effects of budesonide plus formoterol in patients with obstructive airway diseases[J].Drug Des Devel Ther，2015，9：5287.
|
| [18] |
刘葵，刘鳞琛.普米克令舒联合沐舒坦雾化吸入治疗AECOPD 35例疗效观察[J].湖北科技学院学报（医学版），2014，28（1）：28-29.
|
|
|
|
